Impulse Control Disorders Following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: Clinical Aspects

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left"></td><td align="center">PD + DBS</td><td align="center">PD + DA</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">No. of patients</td><td align="center">122</td><td align="center">60</td></tr><tr><td align="left">Gender: M/F/unknown</td><td align="center">62/42/18</td><td align="center">26/11/23</td></tr><tr><td align="left">Mean age (years)</td><td align="center">55</td><td align="center">57</td></tr><tr><td align="left">Mean disease duration (years)</td><td align="center">14</td><td align="center">10</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>Abbreviations. PD: Parkinson’s disease; PD + DBS: patients with Parkinson’s disease who underwent deep brain stimulation surgery (some remained on medication postoperatively); PD + DA: patients with Parkinson’s disease treated with dopaminergic medication.<br/></td></tr></table>

Summary of demographic and clinical characteristics of patients with Parkinson’s disease from four original studies evaluating the effects of deep brain stimulation on impulse control disorders.

Parkinson’s Disease

tab1

Table 1

Table 1: Impulse Control Disorders Following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: Clinical Aspects 